European Companies Search Engine
Capital: €11.6M · Company statute Hrb28 Jan 2011 German Trade Register Announcements, Germany (21/01/2011)
Overview
Text
STRATEC Biomedical Systems AG, Birkenfeld, Gewerbestr. 37, 75217 Birkenfeld. Due to the conditional increase in the share capital (Conditional Capital I (2007)) decided on May 16, 2007, subscription shares with a par value of EUR 115,500.00 were issued between May 25, 2010 and November 10 and 2010; due to the conditional increase in the share capital (Conditional Capital II) decided on May 28, 2003, subscription shares with a par value of EUR 3,790.00 were issued between May 25, 2010 and November 10, 2010; due to the conditional increase in the share capital (Conditional Capital III) decided on June 23, 2006, subscription shares with a par value of EUR 4,000.00 were issued between May 25, 2010 and November 10 and 2010. The share capital is thus increased by EUR 123,290.00. On December 17, 2010, the Supervisory Board approved the amendment of the Articles of Association to Section 4 (share capital). Share capital now: EUR 11,569,026.00. The balance of the conditional capital decided on May 16, 2007 (Conditional Capital I (2007)) is still EUR 97,400.00 after partial exhaustion. The balance of the conditional capital (Conditional Capital II) decided on May 28, 2003 is still EUR 42,420.00 after partial exhaustion. The balance of the conditional capital (Conditional Capital III) decided on June 23, 2006 is still EUR 19,300.00 after partial utilization.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: STRATEC SE, Birkenfeld, Germany.
The visualizations for "STRATEC Biomedical Systems AG - Capital: €11.6M · Company statute"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
